Hosted on MSN22d
FDA recognizes need for immunogenicity assays in therapeutics with carriers or conjugatesMore information: David P. Chimento et al, Bioanalytical Assays for Oligonucleotide Therapeutics: Adding Antibody-Based Immunoassays to the Toolbox as an Orthogonal Approach to LC-MS/MS and Ligand ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback